Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Godenèche

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1987
Disposition of new sulphur-containing 2-(chloroethyl)nitrosoureas in ratsD Godenèche, J C Madelmont, P Labarre, et al.
Cancer Research|September 1, 1980
Disposition of the carcinostatic agent 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha,beta-d-ribofuranosyl]-1-nitrosourea in animalsD Godenèche, J C Madelmont, M F Moreau, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustardsD Godenèche, J C Madelmont, M F Moreau, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|May 1, 1975
[Mode of action of chlorambucil. Initial metabolic studies using carbon 14 isotope labeling. Rheumatological implications of their results]B Sauvezie, S Rampon, J L Bussière, et al.
British Journal of Pharmacology|November 1, 1986
Cytostatic action of two nitrosoureas derived from cysteamineC Bourut, E Chenu, D Godenèche, et al.
Anti-Cancer Drugs|June 1, 1992
Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation schemeB Kim-Triana, J L Misset, J C Madelmont, et al.
Drugs Under Experimental and Clinical Research|January 1, 1992
Phase I trial of cystemustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation schemeG Mathé, J L Misset, B K Triana, et al.
IARC Scientific Publications|January 1, 1991
Excision of imidazole ring-opened N7-hydroxyethylguanine from chloroethylnitrosourea-treated DNA by Escherichia coli formamidopyrimidine-DNA glycosylaseJ Laval, F Lopès, J C Madelmont, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1987
Disposition of new sulphur-containing 2-(chloroethyl)nitrosoureas in ratsD Godenèche, J C Madelmont, P Labarre, et al.
Cancer Research|September 1, 1980
Disposition of the carcinostatic agent 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha,beta-d-ribofuranosyl]-1-nitrosourea in animalsD Godenèche, J C Madelmont, M F Moreau, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustardsD Godenèche, J C Madelmont, M F Moreau, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|May 1, 1975
[Mode of action of chlorambucil. Initial metabolic studies using carbon 14 isotope labeling. Rheumatological implications of their results]B Sauvezie, S Rampon, J L Bussière, et al.
British Journal of Pharmacology|November 1, 1986
Cytostatic action of two nitrosoureas derived from cysteamineC Bourut, E Chenu, D Godenèche, et al.
Anti-Cancer Drugs|June 1, 1992
Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation schemeB Kim-Triana, J L Misset, J C Madelmont, et al.
Drugs Under Experimental and Clinical Research|January 1, 1992
Phase I trial of cystemustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation schemeG Mathé, J L Misset, B K Triana, et al.
IARC Scientific Publications|January 1, 1991
Excision of imidazole ring-opened N7-hydroxyethylguanine from chloroethylnitrosourea-treated DNA by Escherichia coli formamidopyrimidine-DNA glycosylaseJ Laval, F Lopès, J C Madelmont, et al.
Pageof 1